Merideth MA

No ORCID on file · 4 papers in corpus · active 2020-2026

Study types

  • other 2
  • article 1

Condition tags

  • endometriosis 1
  • chronic_pelvic_pain 1
article 2026
Botulinum toxin for endometriosis-associated chronic pelvic pain: a randomised, double-masked, parallel, phase 2 trial
EClinicalMedicine ·doi:10.1016/j.eclinm.2025.103740

BACKGROUND: Chronic pelvic pain affects one in four women. Botulinum toxin, approved for chronic migraine and cervical dystonia pain, is an emerging treatment for other pain conditions. We evaluated intramuscular pelvic floor botulinum toxi…

other 2025
Genital Graft-Versus-Host-Disease Predicts Decreased Sexual Function in Female Survivors of Allogeneic Hematopoietic Stem Cell Transplant
Transplantation and cellular therapy ·doi:10.1016/j.jtct.2025.06.021

BACKGROUND: Impaired sexual health is a common long-term issue for female allogeneic hematopoietic stem cell transplant survivors. OBJECTIVE(S): To compare sexual function among clinically stable female transplant survivors to age-matched …

other 2024
Human papillomavirus disease in GATA2 deficiency: a genetic predisposition to HPV-associated female anogenital malignancy
Frontiers in immunology ·doi:10.3389/fimmu.2024.1445711

OBJECTIVE: Patients with pathogenic variants in the GATA Binding Protein 2 (GATA2), a hematopoietic transcription factor, are at risk for human papillomavirus-related (HPV) anogenital cancer at younger than expected ages. A female cohort wi…

2020
Gynecologic and reproductive health in patients with pathogenic germline variants in DICER1.
Gynecologic Oncology ·doi:10.1016/j.ygyno.2019.12.037

ObjectiveGermline pathogenic variation in DICER1 underlies a tumor-predisposition disorder with increased risk for cervical embryonal rhabdomyosarcoma and ovarian sex-cord stromal tumors, particularly Sertoli-Leydig cell tumors. The gynecol…